Smith & Nephew Snats (SNN) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Smith+Nephew, a global medical technology company, has announced the appointment of Angie Risley as Senior Independent Director starting October 1, 2024. Risley, who will continue as Chair of the Remuneration Committee and a member of the Nomination & Governance Committee, succeeds Marc Owen, who retains his roles within the company’s various committees. The company emphasizes its commitment to medical technology innovation aimed at improving patient outcomes and restoring self-belief.
For further insights into SNN stock, check out TipRanks’ Stock Analysis page.